Skip to content

Comparison of the analgesic effect of paracetamol and morphine with morphine alone in patients with abdominal pain suspected biliary origin

Comparison of analgesic effect of paracetamol and morphine VS morphine in abdominal pain with suspected biliary origin in the Emergency Department of Shariati and Imam Khomeini Hospitals

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201206099984N1
Enrollment
90
Registered
2012-10-08
Start date
2012-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal pains with biliary origin. Pain localized to upper abdomen

Interventions

Intervention 1: For the intervention group we infused 1000mg paracetamol in 100 cc normal salin over 15 min and 0.05mg/kg morphine that diluted in 5cc normal salin over 5 mins. Intervention 2: In the
Treatment - Drugs
Placebo
For the intervention group we infused 1000mg paracetamol in 100 cc normal salin over 15 min and 0.05mg/kg morphine that diluted in 5cc normal salin over 5 mins.
In the control group we infused 0.1mg/kg morphine diluted into 5 ml normal saline within 5 mins.
In the control group we infused 100 cc normal saline within 15 mins.

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Aged = 18 and =65 years; Abdominal pain that clinical or Para clinical (evidence of gallbladder or biliary tract stones during the last 12 months) is in favor of biliary origin; NRS = 3. Exclusion criteria: Aged ?18 years and ?65years; Known hypersensitivity to opioids or paracetamol; Unstable vital signs: systolic blood pressure ?90mmHg; Evidence of peritoneal irritation; Pregnancy; Prior to entering the study; Patients with known renal, hepatic or cardiac failure; Patients with transplants (kidney, lung, liver, or heart); Lack of patient consent for participation in the study; Decreased level of consciousness (GCS ?15); Mental retardation; NRS ?3; having received Analgesics during the last 6 hours before presenting to the emergency department; Addiction to opium or methadone use.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The analgesic effect of drugs. Timepoint: Immediately before, 15, 30 minutes after drugs administration. Method of measurement: Pain scores (VAS, NRS).

Secondary

MeasureTime frame
Requirement to rescue doses of fentanyl. Timepoint: No significant reduction in pain 30 minutes after drug administration (difference between first and last VAS ?3 mm) and ask for pain medication by the patient at any time during the one hour under the observation. Method of measurement: Clinical examination and asking the patient.;Pruritus, Rash. Timepoint: Within one hour after administration of drugs. Method of measurement: Clinical examination and questionnaire.;Dizziness. Timepoint: Within one hour after administration of drugs. Method of measurement: Clinical examination and questionnaire.;Nausea and vomiting. Timepoint: Within one hour after administration of drugs. Method of measurement: Clinical examination and questionnaire.;Hypotension. Timepoint: Within one hour after administration of drugs. Method of measurement: Clinical examination and questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabaei Rasoul

Shariati Hospital

r-babaei@razi.tums.ac.ir; rasoul.babaei@gmail.com+98 21 8490 2719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026